Strontium ranelate
Key facts
| Invented name |
Osseor
|
| Active substance |
strontium ranelate
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/24/2010
|
| PIP number |
Strontium ranelate
|
| Pharmaceutical form(s) |
Granules for oral suspension
|
| Condition(s) / indication(s) |
Osteoporosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Les Laboratoires Servier
E-mail: mail.pip.enquiries@servier.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|